Ibrutinib-biotin is a probe that consists of Ibrutinib linked to biotin via a long chain linker, extracted from patent WO2014059368A1 Compound 1-5, has an IC 50 of 0.755-1.02 nM for BTK .
In Vitro
Ibrutinib-biotin (Compound 1-5) is a probe that consists of Ibrutinib linked to biotin via a long chain linker. Ibrutinib is a TEC family kinase inhibitor. The TEC kinase family is composed of five members, TEC, BTK (Bruton's Tyrosine Kinase), ITK (interleukin-2-inducible T-cell kinase)/EMT/TSK, BMX and TXK/RLK. The TEC family kinases participate in phosphotyrosine- mediated and phospholipid-mediated signaling systems. Many TEC family proteins are abundantly expressed in hematopoietic tissues, and play important roles in the growth and differentiation processes of blood cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Ibrutinib-biotin is a probe that consists of Ibrutinib linked to biotin via a long chain linker, extracted from patent WO2014059368A1 Compound 1-5, has an IC 50 of 0.755-1.02 nM for BTK .
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
INHIBITOR
Purity
≥99%
Names and Identifiers
Molecular Weight
1097.37
Advanced Data
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
Solubility
DMSO : 50 mg/mL (45.56 mM; Need ultrasonic)
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Reviews
Customer Reviews
Application Protocols
Validated, item-specific protocols (e.g., recommended concentrations, incubation times, and positive controls) are not provided in the Product Data for this SKU.
Not specified for this item; refer to CoA/Spec Sheet and SDS. If a technical datasheet is available for this lot, follow those instructions.
General guidance (non-SKU-specific) relevant to biotinylated covalent kinase probes is outlined in the Reaction Conditions section and should be adapted and validated empirically for your system.
Biological Roles
Mechanistic role (literature/general for ibrutinib-derived probes):
The ibrutinib pharmacophore covalently modifies nucleophilic cysteine residues via its acrylamide Michael acceptor, most notably BTK at Cys481 within the ATP-binding site. This yields irreversible occupancy under physiological conditions.
Off-target engagement has been observed for related kinases (e.g., TEC family) and certain EGFR family mutants in ibrutinib literature; biotin tagging allows proteome-wide profiling of such interactions in cells or lysates.
Use in chemical biology:
Facilitates identification and enrichment of direct binding partners by streptavidin affinity capture, enabling downstream immunoblotting or shotgun proteomics.
Supports engagement/displacement studies to quantify target residence time and competition with endogenous ligands or inhibitors.
Enables site mapping of covalent adducts via tandem MS peptide analysis when combined with suitable digestion and enrichment protocols.
Cellular considerations (general):
Permeability is typically sufficient for live-cell labeling with short incubations; however, the biotin tag and linker can modulate uptake and distribution—optimize exposure and temperature.
Free extracellular biotin or high-biotin media supplements do not typically compete with intracellular covalent binding but can influence streptavidin-based detection if carryover occurs in lysate.
Note: This section summarizes general literature behavior of ibrutinib-biotin probes. No medical or clinical claims are made; this product is for research use only.
Buffer Applications
This item is not a buffering agent and is not typically used to prepare or maintain pH in biochemical assays.
Practical note: Select buffers that are compatible with covalent labeling chemistry and downstream streptavidin capture (e.g., HEPES or PBS at neutral pH). Avoid high concentrations of reducing agents (DTT, βME) or nucleophilic additives prior to labeling, as these can quench the acrylamide warhead.
Additives: Low percentages of DMSO (≤0.1–0.5%) are commonly tolerated in live-cell assays; mild nonionic detergents (e.g., 0.1% NP-40/Triton X-100) may be used in lysis buffers post-labeling for efficient extraction (general guidance).
Green Alternatives
Solvent and workflow considerations:
Prefer DMSO at minimal effective percentages in aqueous buffers; consider greener cosolvents such as glycerol, PEG-400, or propylene carbonate for stock or intermediate dilutions if compatible with your assay (general). Validate biological compatibility.
Replace DMF where possible with more benign options (e.g., DMSO, Cyrene) for in vitro labeling setups, subject to solubility and target stability testing.
Solid-phase capture sustainability:
Streptavidin resins can often be regenerated and reused with appropriate denaturing washes (e.g., 6 M guanidine HCl or 8 M urea) to reduce consumable waste; verify resin specifications.
Comparison of options (general):
DMSO: high solvency, broadly accepted in biology; moderate EHS profile; widely recyclable at scale but not typical in labs.
Cyrene (dihydrolevoglucosenone): bio-based dipolar aprotic; promising but may be harsher to proteins and less compatible with live cells; evaluate case-by-case.
Aqueous-first approaches: direct dissolution is greener but often impractical due to limited solubility; microemulsions or carrier proteins may help but can alter assay specificity.
Probe design alternatives:
Desthiobiotin tags enable milder elution (competitive elution with biotin) reducing harsh conditions and potential protein damage, at the cost of slightly weaker binding; consider if resin regeneration and gentler workflows are priorities (general literature note).
Green choices must balance chemical compatibility, biological integrity, and data quality; pilot experiments are essential.
Pharmaceutical Uses
Not intended for human or veterinary use. This product is a research probe and not an excipient or active pharmaceutical ingredient for formulation.
Research/manufacturing context (general):
In drug discovery, biotinylated inhibitor probes are used for target deconvolution, mechanism-of-action studies, and chemoproteomic profiling during lead optimization.
Can inform selectivity landscapes of covalent kinase inhibitors by enabling enrichment and identification of labeled proteins under physiologically relevant conditions.
No pharmacopeial status or excipient role is specified for this SKU; refer to CoA/Spec Sheet for any regulatory notes pertinent to laboratory procurement and handling.
Physical Properties
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Melting point, boiling point, density, refractive index: Not specified for this item; refer to CoA/Spec Sheet.
Solubility (general/literature guidance for biotinylated small-molecule probes):
Typically soluble in polar aprotic organic solvents such as DMSO and DMF at millimolar concentrations (literature/practice).
Aqueous solubility is commonly limited unless aided by co-solvents (e.g., 1–5% DMSO) or surfactants; the biotin/linker can improve amphiphilicity but may not ensure high aqueous solubility (literature/general).
LogP/pKa: Not specified for this item; refer to CoA/Spec Sheet. For related ibrutinib scaffolds, lipophilicity is moderate-to-high, but the appended biotin/linker modifies this (general literature note; not item-specific).
Stability (general):
Acrylamide warhead is moisture-stable but can undergo Michael addition with strong nucleophiles; avoid prolonged exposure to basic buffers containing high thiol concentrations without protein present (general).
Protect from light and repeated freeze–thaw to minimize degradation of conjugated systems (general).
All numerical specifications should be confirmed against the product CoA/SDS; values are not provided for this specific SKU.
Quality & Grades
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
What grade means (general guidance):
For small-molecule probes, suppliers often specify chemical purity by HPLC/UPLC (area %) and provide identity confirmation by HRMS and/or NMR. Low residual solvents and matched chromatographic purity are important for reproducible biological assays.
If a stabilizer is present (e.g., low % of acid or antioxidant), it will be listed on the CoA; absence of a listing generally implies no added stabilizer. For this SKU, stabilizers are not specified.
Recommended quality controls before use (best practice):
Verify identity by LC–MS in your lab upon first receipt; check the expected [M+H]+ and impurity profile.
Assess purity by analytical HPLC and confirm retention time under your assay mobile phase.
For biotinylated probes, verify functional capture by a quick streptavidin pull-down control and Western blot of known targets (e.g., BTK) prior to large-scale experiments.
UV/fluorescence properties: Not specified for this item; refer to CoA/Spec Sheet. If UV detection is needed, determine λmax empirically in your assay solvent.
Note: CoA/Spec Sheet provides the authoritative specification set for this lot/SKU.
Reaction & Applications
This product is designed as a biochemical/chemical biology probe rather than a synthetic reagent.
Primary research applications (general/literature for ibrutinib-derived biotin probes):
Affinity pull-down/chemical proteomics: covalent engagement of BTK and related TEC-family kinases via the acrylamide warhead, followed by streptavidin capture of labeled proteins for Western blotting or LC–MS/MS identification.
Target engagement assays: CETSA/thermal shift or occupancy competition experiments using the biotin handle for detection.
Competitive profiling: pre-incubation with unlabeled ibrutinib or analogs to assess specificity by competition in pull-down experiments.
Kinase active-site mapping: site-specific covalent labeling at nucleophilic cysteines (e.g., BTK Cys481), enabling mapping of adducts by MS (literature).
Practical notes:
Maintain low free-thiol environments during labeling (avoid DTT/βME before labeling; introduce reducing agents after capture as needed).
Include detergent-compatible streptavidin resins for robust capture from lysates; wash stringently (e.g., high salt, mild detergents) to reduce nonspecific binders.
For live-cell labeling, minimize DMSO (<0.1–0.5%) and optimize exposure time to balance permeability and target occupancy (general guidance).
Controls:
Negative control: inactive/warhead-blocked analog or excess free biotin to assess nonspecific streptavidin interactions.
Competition control: excess ibrutinib to confirm on-target engagement.
Note: Specific validated applications for this SKU are not provided in the Product Data; the above reflects general literature practices for biotinylated ibrutinib probes.
Reaction Conditions
As a chemical biology probe, “reaction conditions” refer to labeling and enrichment workflows rather than classical organic reactions. The following are literature-style general guidelines; they are not item-specific specifications.
Protein/lysate labeling (in vitro):
Buffer: HEPES or PBS, pH 7.2–7.8; avoid reducing agents prior to labeling.
Probe concentration: 0.1–5 µM for purified BTK; 0.5–10 µM for cell lysates depending on protein abundance and complexity.
Temperature/time: 25–37°C for 15–120 min; optimize to balance specificity and extent of labeling.
Quench/controls: Competition with excess ibrutinib (5–50×) to demonstrate specificity; optional thiol scavengers post-labeling.
Live-cell engagement:
Vehicle: DMSO final ≤0.1–0.5%.
Concentration/exposure: 0.1–1 µM, 15–90 min at 37°C (optimize by cell type and permeability).
Washout in warm media prior to lysis to remove unbound probe.
Streptavidin enrichment:
Resin: High-capacity magnetic or agarose streptavidin beads.
Binding: 0.5–2 h at 4–25°C with rotation.
Washes: High-salt (e.g., 500 mM NaCl), detergent (0.1% NP-40), and urea (2 M) sequences to reduce nonspecifics (validate for your targets).
Elution: Boiling in SDS sample buffer for WB; for MS, on-bead digestion with trypsin or competitive elution if using desthiobiotin analogs.
Researchers should empirically optimize concentrations, times, and buffers for their specific systems.
Safety & Handling
GHS classification, signal word, pictograms, H-statements: Not specified for this item; consult the product SDS for authoritative hazard information.
General hazards (class-based, literature):
Small-molecule electrophile containing an acrylamide Michael acceptor; may alkylate biological nucleophiles. Avoid skin contact and inhalation.
Organic compound; treat as potentially harmful if swallowed, inhaled, or absorbed through skin. Handle in a chemical fume hood.
Recommended PPE/practices:
Laboratory coat, nitrile gloves (double-gloving recommended for extended handling), and splash goggles.
Use a certified fume hood; avoid aerosol generation. Decontaminate surfaces with appropriate organic solvent followed by detergent/water.
Incompatibilities (general):
Strong nucleophiles (thiols, primary amines) can react with the acrylamide warhead; minimize contact unless in intended binding assays.
Strong oxidizers and strong bases may promote degradation.
First aid (overview; consult SDS):
Skin contact: Remove contaminated clothing, wash with soap and water. Seek medical attention if irritation persists.
Eye contact: Rinse cautiously with water for several minutes; remove contact lenses if present and easy to do; continue rinsing and seek medical advice.
Inhalation: Move to fresh air; seek medical attention if symptoms occur.
Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.
Waste disposal:
Collect organic solutions and contaminated disposables as hazardous chemical waste; follow institutional and local regulations.
Always refer to the SDS for definitive safety, spill, and firefighting guidance.
Solvent Selection
Polarity/miscibility (general for biotinylated ibrutinib probes):
Readily soluble in DMSO and DMF; often dissolves in acetonitrile or methanol at lower concentrations (literature/practice).
Limited solubility in pure water; use co-solvent strategies (e.g., 0.1–1% DMSO final) or carrier proteins (e.g., 0.1% BSA) as compatible with the assay.
Typical use scenarios:
Prepare concentrated DMSO stocks (e.g., 1–10 mM) for cell-based assays, pulldown labeling, or biochemical target engagement, then dilute into buffered media.
For proteomics workflows, dissolution in DMSO followed by dilution into lysis buffer (non-reducing, low free-thiol) is common to preserve the acrylamide electrophile.
Selection guidance vs alternatives:
DMSO: preferred for maximum solvency and biological compatibility in low percentages.
DMF: strong solvency but less favored in live-cell work; useful for in vitro labeling.
Aqueous buffers: acceptable after cosolvent dilution; avoid high concentrations of free thiols (e.g., DTT, βME) that can quench the probe.
Practical tips:
Warm gently and vortex to aid dissolution; avoid prolonged heating.
Filter sterilize diluted working solutions (0.22 µm) when used in cell assays, avoiding adsorptive losses by pre-wetting filters with solvent.
All solvent choices should be validated for your specific assay compatibility and target stability.
Storage & Reconstitution
Item-specific storage/shipping:
Storage Conditions: Store at -20°C.
Shipped In: Ice chest + Ice pads.
Stock preparation (general guidance):
Reconstitute to a convenient concentration (e.g., 1–10 mM) in anhydrous DMSO. Mix by gentle vortexing and brief sonication if needed. Record the exact concentration by weight-in or spectroscopically if applicable.
Filter-sterilize diluted working solutions (0.22 µm) if used in cell-based assays.
Aliquoting and stability (general guidance):
Aliquot DMSO stock into low-bind microtubes to avoid repeated freeze–thaw; store at -20°C (or below) protected from light and moisture.
Typical working solution lifetime at 4°C is hours to a day; frozen DMSO aliquots are commonly stable for months when protected from moisture and air. Verify integrity by LC–MS/HPLC before critical experiments.
Handling precautions:
Allow frozen aliquots to reach room temperature before opening to prevent moisture ingress; promptly re-cap and refreeze unused portions.
Avoid buffers containing high concentrations of free thiols prior to labeling to prevent warhead quenching.
Note: Where specific stability specifications are required (e.g., shelf life, permissible freeze–thaw cycles), they are not specified for this item; consult the CoA/Spec Sheet.
Structure & Identity
Ibrutinib-biotin is a biotinylated small-molecule probe derived from the covalent Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, functionalized to include a biotin handle (typically via a linker) for streptavidin-based capture.
Item-specific identifiers:
CAS: 1599432-18-4
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general/literature description):
Contains the ibrutinib pharmacophore: an anilide-acrylamide warhead capable of Michael addition to nucleophilic cysteine (e.g., BTK Cys481).
Biotin moiety (ureido-thiophene ring fused to a valeric acid side chain) appended via a flexible linker (length and composition vary by design; commonly PEG or alkyl).
Functional groups: acrylamide Michael acceptor, amide linkages, aromatic heterocycles (as in ibrutinib core), and the biotin imide.
Stereochemistry: biotin is bicyclic with defined stereocenters (literature), whereas the linker/ibrutinib portion may be largely achiral aside from biotin; actual configuration depends on the exact construct.
2D structure in words (general): an ibrutinib-like aryl–heteroaryl framework bearing an electrophilic acrylamide, tethered through an amide/urea/ether linker to biotin’s bicyclic ureido-thiophene system, terminating in a valeramide/ester connection enabling high-affinity streptavidin binding.
Note: Exact atom-level structure and identifiers for this SKU are not specified; consult the CoA/SDS for definitive identity attributes.
Synthetic Utility
This compound is primarily a finished chemical probe rather than a general-purpose synthetic building block.
Utility in methodology development (general):
Serves as a covalent capture handle: the acrylamide warhead forms adducts with protein cysteines, while the biotin tag enables robust immobilization on streptavidin supports. This combination is valuable in developing and benchmarking enrichment chemistries and elution strategies.
Can function as a competitive tool compound in SAR studies—e.g., displacement assays against newly synthesized ibrutinib analogs to quantify target occupancy and relative binding kinetics.
Not typically employed as a precursor in multistep synthesis, given the presence of the biotin macrocycle and the fully elaborated pharmacophore. Any further derivatization (e.g., click handles, fluorophores) is generally performed upstream on the ibrutinib core prior to biotin conjugation or uses orthogonal linkers designed for late-stage modification.
Stability considerations for method development:
Maintain neutral to slightly acidic conditions during manipulations to preserve the Michael acceptor.
Avoid strong nucleophiles/bases unless intentionally quenching or modeling adduct formation.
In summary, consider this SKU a specialized tool for capture-and-detect workflows rather than a modular synthetic intermediate.
Target Specificity
Item-specific target binding data, tested targets, and selectivity panels are not provided in the Product Data for this SKU.
Not specified for this item; refer to CoA/Spec Sheet and any associated technical note. For general background on ibrutinib-derived probes, see the Biological Roles and Reaction & Applications sections, which summarize literature expectations without claiming SKU-specific performance.
Frequently Asked Questions
What is the purity of this product?
This product is supplied at ≥99% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1599432-18-4, the molecular formula is C56H80N12O9S, and the molecular weight is 1097.37 g/mol.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.